Literature DB >> 8203844

Effect of a fat- and calcium-rich breakfast on pharmacokinetics of fleroxacin administered in single and multiple doses.

J S Bertino1, A N Nafziger, M Wong, L Stragand, C Puleo.   

Abstract

The effect of a fat- and liquid-calcium-rich meal on the pharmacokinetics of single and multiple doses of fleroxacin in 20 healthy men and women was investigated in a randomized crossover fashion. Fleroxacin was administered as 400 mg daily for 3 days and as a single 400 mg dose. Concurrent administration of fleroxacin with food resulted in a statistically significant (P < or = 0.05) decrease in the area under the curve (13.9% for multiple-dose administration, 10% for single-dose administration) and in the peak concentration (25.9% for multiple-dose administration, 27% for single-dose administration) and a lengthening of the time to peak (more than doubled for single- and multiple-dose phases). In addition, by using an equivalence criteria of 80 to 125%, the two one-sided tests procedure indicated that the mean areas under the curves for fleroxacin administered in a fed and a fasted state were statistically bioequivalent (P < or = 0.05) for both the single- and multiple-dose regimens. Although a meal high in fat and containing liquid calcium reduces the peak concentration by approximately 25%, a minimal effect on bioavailability is seen with concomitant food administration. In addition, multiple-dose bioavailability studies appear to give similar information to single-dose studies while representing the clinical setting more closely.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8203844      PMCID: PMC284487          DOI: 10.1128/AAC.38.3.499

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

Review 1.  Controversies in bioequivalence studies.

Authors:  V W Steinijans; D Hauschke; J H Jonkman
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

2.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

3.  Effect of food on absorption of lomefloxacin.

Authors:  W D Hooper; R G Dickinson; M J Eadie
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

4.  Ciprofloxacin pharmacokinetics after a standard or high-fat/high-calcium breakfast.

Authors:  R W Frost; J D Carlson; A J Dietz; A Heyd; J T Lettieri
Journal:  J Clin Pharmacol       Date:  1989-10       Impact factor: 3.126

5.  In vitro activity of Ro 23-6240, a new fluorinated 4-quinolone.

Authors:  N X Chin; D C Brittain; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

6.  A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability.

Authors:  D J Schuirmann
Journal:  J Pharmacokinet Biopharm       Date:  1987-12

7.  Effect of food on enoxacin absorption.

Authors:  A A Somogyi; F Bochner; J A Keal; P E Rolan; M Smith
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

8.  The effect of food on the pharmacokinetics of ofloxacin.

Authors:  M Verho; V Malerczyk; E Dagrosa; A Korn
Journal:  Curr Med Res Opin       Date:  1986       Impact factor: 2.580

9.  Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin.

Authors:  B Ledergerber; J D Bettex; B Joos; M Flepp; R Lüthy
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

10.  Clinical pharmacokinetics and tolerance of fleroxacin in healthy male volunteers.

Authors:  M Nakashima; M Kanamaru; T Uematsu; A Takiguchi; A Mizuno; T Itaya; F Kawahara; T Ooie; S Saito; H Uchida
Journal:  J Antimicrob Chemother       Date:  1988-10       Impact factor: 5.790

View more
  7 in total

1.  Effects of milk and food on the absorption of enoxacin.

Authors:  P Lehto; K T Kivistö
Journal:  Br J Clin Pharmacol       Date:  1995-02       Impact factor: 4.335

Review 2.  Effects of food on clinical pharmacokinetics.

Authors:  B N Singh
Journal:  Clin Pharmacokinet       Date:  1999-09       Impact factor: 6.447

3.  Pharmacokinetics of oral fleroxacin in male and premenopausal female volunteers.

Authors:  J S Bertino; A N Nafziger
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

4.  Pharmacokinetics of fleroxacin after multiple oral dosing in patients receiving regular hemodialysis.

Authors:  D E Uehlinger; F Schaedeli; M Kinzig; F Sörgel; F J Frey
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

Review 5.  Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections.

Authors:  J A Balfour; P A Todd; D H Peters
Journal:  Drugs       Date:  1995-05       Impact factor: 9.546

Review 6.  Absorption interactions with fluoroquinolones. 1995 update.

Authors:  B M Lomaestro; G R Bailie
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

Review 7.  Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.

Authors:  R Davis; A Markham; J A Balfour
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.